Market closed
Sanara MedTech/$SMTI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Sanara MedTech
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Ticker
$SMTI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
108
Website
Sanara MedTech Metrics
BasicAdvanced
$313M
Market cap
-
P/E ratio
-$0.99
EPS
1.56
Beta
-
Dividend rate
Price and volume
Market cap
$313M
Beta
1.56
52-week high
$43.25
52-week low
$26.00
Average daily volume
34K
Financial strength
Current ratio
2.225
Quick ratio
1.91
Long term debt to equity
79.798
Total debt to equity
80.911
Interest coverage (TTM)
-3.13%
Management effectiveness
Return on assets (TTM)
-5.08%
Return on equity (TTM)
-20.28%
Valuation
Price to revenue (TTM)
3.881
Price to book
7.88
Price to tangible book (TTM)
-53.62
Price to free cash flow (TTM)
-152.037
Growth
Revenue change (TTM)
24.66%
Earnings per share change (TTM)
-0.51%
3-year revenue growth (CAGR)
52.75%
3-year earnings per share growth (CAGR)
13.91%
What the Analysts think about Sanara MedTech
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Sanara MedTech stock.
Sanara MedTech Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Sanara MedTech News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Sanara MedTech stock?
Sanara MedTech (SMTI) has a market cap of $313M as of December 13, 2024.
What is the P/E ratio for Sanara MedTech stock?
The price to earnings (P/E) ratio for Sanara MedTech (SMTI) stock is 0 as of December 13, 2024.
Does Sanara MedTech stock pay dividends?
No, Sanara MedTech (SMTI) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next Sanara MedTech dividend payment date?
Sanara MedTech (SMTI) stock does not pay dividends to its shareholders.
What is the beta indicator for Sanara MedTech?
Sanara MedTech (SMTI) has a beta rating of 1.56. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.